Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Ailsa Budden
Advertisement
Senior Director, Global Medical Education—Oncology, Eli Lilly
Articles by Ailsa Budden
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
3
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
4
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
5